The D-VC and L-VC applications in high doses in combination with arsenic trioxide induce a potent cytotoxic oxidative stress in KRAS mutant cancer cells [17] and their clinical relevance is yet to be determined by performing clinical trials. The gene discussed is KRAS; the disease is cancer.